Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rayan Novin Pajoohan Pars is a knowledge-based biotechnology company headquartered in Shiraz, Iran, specializing in the development of natural health products, advanced cosmetics, and innovative cancer therapeutics. Founded in 2022 and operating within the Shiraz Science and Technology Park, the company leverages expertise in nanotechnology and microbiology to create high-efficacy formulations. Their commercial portfolio includes a line of natural antioxidant drinks and specialized skincare serums based on hyaluronic acid and turmeric. In the research domain, the company is actively involved in pre-clinical programs focused on phycocyanin-based treatments for colorectal cancer and postbiotic metabolites for cervical malignancy. Rayan Novin Pajoohan Pars maintains strong academic ties with Shiraz University of Medical Sciences and the Pasteur Institute of Iran to drive its R&D initiatives.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rayan Novin Pajoohan Pars.